C1QTNF3 and cardiac hypertrophy: Some studies found that CTRP3 attenuates diabetes-related cardiomyopathy by activating AMPKα (Ma et al., 2017) and attenuates pressure overload-induced cardiac hypertrophy in the animal model (Zhang B. et al., 2019).